U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

How pharmaceutical tariffs could reshape drug pricing, supply chains and domestic production in the United States, according ...

America's pharmaceutical sector is facing huge uncertainty from the tariff threat, cuts at the US Department of Health, and a ...

Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with ...

Trump and his aides have repeatedly shifted their stance on tariffs in the weeks since the president’s “Liberation Day” ...

Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than ...

US President Donald Trump on May 23 threatened to impose a 50 percent tariff on all imports from the European Union.

Instead of battling over tariffs, Washington and Beijing have turned to a potentially far more harmful strategy: flexing their control over global supply chains.

So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

U.S. dependency on China for critical goods like rare earths and pharmaceuticals poses risks. Trump's strategies aim to ...

The president is set to raise tariffs on steel and aluminum this week, even as the courts are challenging the legitimacy of ...

The United States Court of Appeals for the Federal Circuit consolidated and temporarily stayed the first decision from the ...